<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0677776" disease_type="Neoplastic Process" abbrv="">Hereditary Breast and Ovarian Cancer Syndrome</z:e> (HBOCS) and Hereditary Non-<z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">Polyposis</z:e> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal Cancer</z:e> Syndrome (HNPCC, <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch Syndrome</z:e>) are two <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> predisposition syndromes responsible for the majority of hereditary breast and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Carriers of both germline mutations in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> genes BRCA1 or BRCA2 and in mismatch repair (MMR) genes MLH1, MSH2, MSH6 or PMS2 are very rare </plain></SENT>
<SENT sid="2" pm="."><plain>CASE PRESENTATION: We identified germline mutations in BRCA1 and in MSH6 in a patient with increased risk for HBOC diagnosed with <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> at the age of 46 years </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSIONS: Although carriers of mutations in both MMR and BRCA genes are rare in Caucasian populations and anamnestical and histopathological findings may guide clinicians to identify these families, both syndromes can only be diagnosed through a complete gene analysis of the respective genes </plain></SENT>
</text></document>